Literature DB >> 7700644

Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.

M Kondo1, H Suzuki, R Ueda, H Osada, K Takagi, T Takahashi, T Takahashi.   

Abstract

Accumulating evidence suggests that deregulation of the insulin-like growth factor II (IGF2) and H19 genes at 11p15, due to loss of imprinting (LOI), plays a role in the oncogenesis of Wilms' tumors. We previously reported LOI of IGF2 in carcinomas of the lung, a common cancer of adults. We show here that LOI of H19 is also a frequent event in lung cancer development, and correlated with hypomethylation of the promoter region. Furthermore, the present study also revealed that overexpression of H19 is often associated with LOI of H19 in lung cancers retaining both parental alleles, showing a contrast to LOI in Wilms' tumors. Interestingly, in contrast to frequent LOI of the imprinted genes at 11p15, LOI was not observed for the remaining gene known to be imprinted in man, SNRPN at 15q12.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700644

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  73 in total

Review 1.  Genomic imprinting: implications for human disease.

Authors:  J G Falls; D J Pulford; A A Wylie; R L Jirtle
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.

Authors:  Zhijie Zhu; Ling Song; Jun He; Yanan Sun; Xiaomei Liu; Xiaoyan Zou
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 3.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

4.  The product of the imprinted H19 gene is an oncofetal RNA.

Authors:  I Ariel; S Ayesh; E J Perlman; G Pizov; V Tanos; T Schneider; V A Erdmann; D Podeh; D Komitowski; A S Quasem; N de Groot; A Hochberg
Journal:  Mol Pathol       Date:  1997-02

Review 5.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

6.  Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells.

Authors:  Xue Yang; Jee Hoon Song; Yulan Cheng; Wenjing Wu; Tushar Bhagat; Yiting Yu; John M Abraham; Sariat Ibrahim; William Ravich; Bani Chander Roland; Mouen Khashab; Vikesh K Singh; Eun Ji Shin; Xiao Yang; Amit K Verma; Stephen J Meltzer; Yuriko Mori
Journal:  Gut       Date:  2013-09-02       Impact factor: 23.059

7.  In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration.

Authors:  Hua Geng; Heng-Fu Bu; Fangyi Liu; Longtao Wu; Karl Pfeifer; Pauline M Chou; Xiao Wang; Jiaren Sun; Lu Lu; Ashutosh Pandey; Marisa S Bartolomei; Isabelle G De Plaen; Peng Wang; Jindan Yu; Jiaming Qian; Xiao-Di Tan
Journal:  Gastroenterology       Date:  2018-04-03       Impact factor: 22.682

8.  A novel locus for maternally inherited human gingival fibromatosis at chromosome 11p15.

Authors:  Yufei Zhu; Wenxia Zhang; Zhenghao Huo; Yi Zhang; Yu Xia; Bo Li; Xiangyin Kong; Landian Hu
Journal:  Hum Genet       Date:  2006-10-31       Impact factor: 4.132

9.  Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.

Authors:  Yu-Wei Cheng; Kamran Idrees; Richard Shattock; Sajid A Khan; Zhaoshi Zeng; Cameron W Brennan; Philip Paty; Francis Barany
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

10.  Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.

Authors:  I Ariel; H Q Miao; X R Ji; T Schneider; D Roll; N de Groot; A Hochberg; S Ayesh
Journal:  Mol Pathol       Date:  1998-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.